Dr. Deborah W. Wilbur
Claim this profileOncology Associates at Mercy Medical Center
Expert in Skin Cancer
Expert in Breast Cancer
73 reported clinical trials
145 drugs studied
Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderHER2 positive
Stage III
Stage IV
Affiliated Hospitals
Oncology Associates At Mercy Medical Center
Mercy Hospital
Clinical Trials Deborah W. Wilbur is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
BRAF-Targeted Therapy
for Colon Cancer
This phase II/III trial compares treatment with encorafenib and cetuximab to usual care (patient observation) for reducing the chance of cancer recurrence after standard surgery and chemotherapy in patients with BRAF-mutated stage IIB-III colon cancer. Encorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of tumor cells. This may help keep tumor cells from growing. Giving encorafenib and cetuximab after standard surgery and chemotherapy may be more effective at reducing the chance of cancer recurrence compared to the usual patient observation.
Recruiting1 award Phase 2 & 3
More about Deborah W. Wilbur
Clinical Trial Related1 year of experience running clinical trials · Led 73 trials as a Principal Investigator · 47 Active Clinical TrialsTreatments Deborah W. Wilbur has experience with
- Pembrolizumab
- Carboplatin
- Biospecimen Collection
- Paclitaxel
- Nivolumab
- Fluorouracil
Breakdown of trials Deborah W. Wilbur has run
Skin Cancer
Breast Cancer
Breast cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deborah W. Wilbur specialize in?
Deborah W. Wilbur focuses on Skin Cancer and Breast Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Deborah W. Wilbur currently recruiting for clinical trials?
Yes, Deborah W. Wilbur is currently recruiting for 43 clinical trials in Cedar Rapids Iowa. If you're interested in participating, you should apply.
Are there any treatments that Deborah W. Wilbur has studied deeply?
Yes, Deborah W. Wilbur has studied treatments such as Pembrolizumab, Carboplatin, Biospecimen Collection.
What is the best way to schedule an appointment with Deborah W. Wilbur?
Apply for one of the trials that Deborah W. Wilbur is conducting.
What is the office address of Deborah W. Wilbur?
The office of Deborah W. Wilbur is located at: Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa 52403 United States. This is the address for their practice at the Oncology Associates at Mercy Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.